Newsroom
Category
December 6, 2012
A tool called microarray testing can help doctors to more often pinpoint the potential genetic reason for a stillbirth, so that more couples can learn what happened to their babies, a study of 500 stillbirths in San Antonio and four other cities showed.
December 6, 2012
Doctoral students, nursing students, and officials of the UT Health Science Center San Antonio and the Baptist Health Foundation of San Antonio are celebrating $1.5 million in gifts from the estate of Laura A. Adler in memory of her husband, Harry F. Adler, M.D., Ph.D.
December 5, 2012
etails concerning the licensing of rapamycin-related intellectual property developed at the UT Health Science Center San Antonio to an emerging spin-out company, Rapamycin Holdings Inc. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potential to slow the aging process and its efficacy in treating age-related diseases.
December 4, 2012
The 35th annual CTRC-AACR San Antonio Breast Cancer Symposium, where close to 7,500 researchers, clinicians and advocates from around the world are gathering to present and hear about the latest research, trends and topics of discussion in breast cancer, including drug trials and treatment methods.
December 1, 2012
In a free Dec. 8 public lecture, Ian M. Thompson Jr., M.D., will discuss the latest information in prostate cancer prevention and treatment.
November 29, 2012
Close to 7,500 researchers, clinicians and advocates will gather here next week at one of the largest breast cancer symposiums in the world.